Shares of Tissue Regenix Group plc (LON:TRX – Get Free Report) passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 58.20 ($0.73) and traded as high as GBX 60 ($0.75). Tissue Regenix Group shares last traded at GBX 60 ($0.75), with a volume of 12,966 shares.
Tissue Regenix Group Price Performance
The company has a debt-to-equity ratio of 35.69, a quick ratio of 2.36 and a current ratio of 3.74. The stock’s 50-day moving average is GBX 58.33 and its two-hundred day moving average is GBX 60.75. The stock has a market cap of £42.74 million, a PE ratio of -6,000.00 and a beta of 1.61.
About Tissue Regenix Group
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. The company operates through dCELL, BioRinse, and GBM-V segments. It also provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth.
Read More
- Five stocks we like better than Tissue Regenix Group
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Work and Play: Investing in the Rise of Bleisure Travel
- Canadian Penny Stocks: Can They Make You Rich?
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- Using the MarketBeat Stock Split Calculator
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
